137 related articles for article (PubMed ID: 37539500)
21. Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Meves A; Nikolova E; Heim JB; Squirewell EJ; Cappel MA; Pittelkow MR; Otley CC; Behrendt N; Saunte DM; Lock-Andersen J; Schenck LA; Weaver AL; Suman VJ
J Clin Oncol; 2015 Aug; 33(23):2509-15. PubMed ID: 26150443
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy in melanoma: beyond histologic factors.
Carr MJ; Monzon FA; Zager JS
Clin Exp Metastasis; 2022 Feb; 39(1):29-38. PubMed ID: 34100196
[TBL] [Abstract][Full Text] [Related]
23. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
Eggermont AMM; Bellomo D; Arias-Mejias SM; Quattrocchi E; Sominidi-Damodaran S; Bridges AG; Lehman JS; Hieken TJ; Jakub JW; Murphree DH; Pittelkow MR; Sluzevich JC; Cappel MA; Bagaria SP; Perniciaro C; Tjien-Fooh FJ; Rentroia-Pacheco B; Wever R; van Vliet MH; Dwarkasing J; Meves A
Eur J Cancer; 2020 Nov; 140():11-18. PubMed ID: 33032086
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
26. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
Fujisawa Y; Otsuka F;
Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients.
Kibrité A; Milot H; Douville P; Gagné ÉJ; Labonté S; Friede J; Morin F; Ouellet JF; Claveau J
Am J Surg; 2016 Jan; 211(1):89-94. PubMed ID: 26275921
[TBL] [Abstract][Full Text] [Related]
28. Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
Hao H; Xiao D; Pan J; Qu J; Egger M; Waigel S; Sanders MA; Zacharias W; Rai SN; McMasters KM
Ann Surg Oncol; 2017 Jan; 24(1):108-116. PubMed ID: 27663566
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.
Farrow NE; Holl EK; Jung J; Gao J; Jung SH; Al-Rohil RN; Selim MA; Mosca PJ; Ollila DW; Antonia SJ; Tyler DS; Nair SK; Beasley GM
Ann Surg Oncol; 2021 Jul; 28(7):3501-3510. PubMed ID: 33205334
[TBL] [Abstract][Full Text] [Related]
30. Factors Affecting Dermatologists' Use of a 31-Gene Expression Profiling Test as an Adjunct for Predicting Metastatic Risk in Cutaneous Melanoma.
Svoboda RM; Glazer AM; Farberg AS; Rigel DS
J Drugs Dermatol; 2018 May; 17(5):544-547. PubMed ID: 29742186
[TBL] [Abstract][Full Text] [Related]
31. Impact of Gene Expression Profiling on Decision-Making in Clinically Node Negative Melanoma Patients after Surgical Staging.
Schuitevoerder D; Heath M; Cook RW; Covington KR; Fortino J; Leachman S; Vetto JT
J Drugs Dermatol; 2018 Feb; 17(2):196-199. PubMed ID: 29462228
[TBL] [Abstract][Full Text] [Related]
32. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
33. Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma.
van Akkooi ACJ; Schadendorf D; Eggermont AMM
Eur J Cancer; 2023 Mar; 182():163-169. PubMed ID: 36681612
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
35. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph-node biopsy for melanoma of the trunk and extremities: the McGill experience.
Tremblay F; Louffi A; Shibata H; Meterissian S
Can J Surg; 2001 Dec; 44(6):428-31. PubMed ID: 11764875
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
38. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
Gerami P; Cook RW; Russell MC; Wilkinson J; Amaria RN; Gonzalez R; Lyle S; Jackson GL; Greisinger AJ; Johnson CE; Oelschlager KM; Stone JF; Maetzold DJ; Ferris LK; Wayne JD; Cooper C; Obregon R; Delman KA; Lawson D
J Am Acad Dermatol; 2015 May; 72(5):780-5.e3. PubMed ID: 25748297
[TBL] [Abstract][Full Text] [Related]
40. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
